Is rare-diseases.at Safe? Security Analysis for Ludwig Boltzmann Gesellschaft
http://rare-diseases.atCheck if rare-diseases.at is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for rare-diseases.at
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
The Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD) is a specialized Austrian research institute focused on investigating rare diseases, particularly those affecting the immune system, blood formation, and nervous system. The institute operated for seven years until March 2023, contributing valuable scientific insights and supporting patients through its research. The website serves as an informational platform targeting researchers, medical professionals, and affected patients, providing news, research areas, and organizational information. The business model is non-profit, funded by grants and public sources, and it operates under the Ludwig Boltzmann Gesellschaft umbrella. Technically, the website is built on WordPress and hosted on servers associated with domaindiscount24.net. While the site has a professional design with good navigation and mobile optimization, it suffers from critical security shortcomings, notably the absence of a valid SSL certificate and HTTPS support. This exposes visitors to potential risks and undermines trust. The site uses Matomo analytics for user tracking and includes a cookie consent banner, indicating some level of privacy compliance, though GDPR compliance is not fully evident. Security posture is weak due to missing HTTPS, lack of security headers, and outdated SSL/TLS configurations. No incident response or security policies are publicly disclosed. Contact information is clearly provided, including phone, address, and an obfuscated email address. Social media presence is active across major platforms, enhancing outreach and trust. Overall, the website is functional and informative but requires urgent security improvements to protect users and enhance credibility. Strategic recommendations include implementing HTTPS, improving security headers, and enhancing privacy compliance documentation.
Detected Technologies
13 urgent findings need attention
4 critical · 9 high
- + 5 more findings in the full report below
Keep rare-diseases.at under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
8 findings
15/100
GDPR Compliance
7 findings
0/100
NIS2 Compliance
8 findings
5/100
Email Security
1 finding
50/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
LBI-RUD holds a niche position in the Austrian healthcare research sector, focusing on rare diseases with a strong scientific foundation. Its affiliation with the Ludwig Boltzmann Gesellschaft lends credibility and access to funding. The institute's research areas cover immunology, neurobiology, bioinformatics, and bioethics, targeting a specialized audience of researchers and clinicians. The business model is grant-funded non-profit research, with no commercial activities evident. The website supports dissemination of research findings and institutional news, fostering community engagement. Partnerships appear limited to the parent organization and scientific collaborators. Growth indicators are not explicit, but the closure in 2023 suggests project lifecycle completion. The digital presence is moderate, with room for technical and security enhancements to support future initiatives or successor projects.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The current security posture of the website is poor. The absence of a valid SSL certificate and HTTPS support is a critical vulnerability, exposing users to data interception and undermining trust. No advanced security headers or mechanisms such as HSTS, CSP, or OCSP stapling are implemented. TLS protocols are not supported, indicating outdated or misconfigured server security. No incident response or vulnerability disclosure policies are visible, limiting transparency and preparedness. The site does not appear to collect sensitive data via forms, reducing immediate risk, but the lack of secure transport remains a major concern. Privacy compliance is partially addressed through cookie consent, but GDPR adherence is unclear. Overall, the site requires urgent remediation to meet basic security standards and protect user data.
Strategic Recommendations
Priority Actions for Security Improvement
Obtain and deploy a valid SSL/TLS certificate to enable HTTPS across the entire site.
Get this report delivered to your inbox
Receive a summary of the rare-diseases.at security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Insufficient contact information
MEDIUMGDPR requires organizations to provide clear contact details
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
EU business without adequate privacy measures
CRITICALEU businesses are subject to strict GDPR requirements
No HTTPS encryption
CRITICALGDPR requires appropriate security measures for personal data
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No HTTPS encryption
CRITICALNIS2 requires appropriate technical measures including encryption
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete rare-diseases.at security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
Email Security Check Incomplete
MEDIUMSome email security checks timed out
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
No HTTPS Encryption
CRITICALWebsite does not use HTTPS encryption, making all data transmission vulnerable to interception
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
DNS Records
DNSSEC Status
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does rare-diseases.at compare?
rare-diseases.at scores below average. Browse similar domains to see how competitors handle security.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the rare-diseases.at report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Want OffSeq to fix this?
Book a 30-minute remediation call
Our security engineers can resolve the high-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.
OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services
Scan your own website
Liked the rare-diseases.at report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about rare-diseases.at
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published